Ambrx Biopharma, Inc. (AMAM)
NYSE: AMAM · IEX Real-Time Price · USD
3.85
-0.15 (-3.75%)
May 20, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 7.46 | 13.67 | 10.31 |
| Revenue Growth (YoY) | -45.47% | 32.59% | - |
| Gross Profit | 7.46 | 13.67 | 10.31 |
| Selling, General & Admin | 17.07 | 6.35 | 6.4 |
| Research & Development | 54.81 | 20.43 | 26.38 |
| Operating Expenses | 71.88 | 26.79 | 32.78 |
| Operating Income | -64.42 | -13.12 | -22.47 |
| Other Expense / Income | 3.65 | 3.43 | -2.41 |
| Pretax Income | -68.08 | -16.54 | -20.06 |
| Income Tax | 0 | 0 | -0 |
| Net Income | -68.08 | -16.54 | -20.06 |
| Net Income Common | -68.08 | -16.54 | -20.06 |
| Shares Outstanding (Basic) | 143 | 116 | 136 |
| Shares Outstanding (Diluted) | 143 | 116 | 136 |
| Shares Change | 23.77% | -15.01% | - |
| EPS (Basic) | -3.36 | -0.98 | -1.05 |
| EPS (Diluted) | -3.36 | -0.98 | -1.05 |
| Free Cash Flow Per Share | -2.28 | -1.26 | -0.14 |
| Gross Margin | 100.00% | 100.00% | 100.00% |
| Operating Margin | -864.17% | -95.93% | -217.94% |
| Profit Margin | -913.20% | -121.01% | -194.57% |
| Free Cash Flow Margin | -625.03% | -152.35% | -27.28% |
| Effective Tax Rate | -0.00% | -0.01% | 0.01% |
| EBITDA | -64.34 | -13.12 | -16.53 |
| EBITDA Margin | -863.07% | -95.98% | -160.35% |
| EBIT | -68.08 | -16.54 | -20.06 |
| EBIT Margin | -913.19% | -121.00% | -194.59% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).